carvedilol has been researched along with Mesenteric Vascular Occlusion in 1 studies
Mesenteric Vascular Occlusion: Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christopher, TA | 1 |
| Lopez, BL | 1 |
| Yue, TL | 1 |
| Feuerstein, GZ | 1 |
| Ruffolo, RR | 1 |
| Ma, XL | 1 |
1 other study available for carvedilol and Mesenteric Vascular Occlusion
| Article | Year |
|---|---|
Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Endothelium, Vascular; Free Radical Sc | 1995 |